H.Res. 279 (112th): Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.
May 25, 2011
112th Congress, 2011–2013
Died in a previous Congress
This resolution was introduced on May 25, 2011, in a previous session of Congress, but was not enacted.
Representative for Kentucky's 6th congressional district
Read Text »
Last Updated: May 25, 2011
Length: 3 pages
About the resolution
- Summary (CRS)
- 5/25/2011--Introduced.Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of ...
- What is a resolution?
The “H.Res.” in “H.Res. 279” means this is a House simple resolution in the United States Congress. A simple resolution is used for matters that affect just one chamber of Congress, often to change the rules of the chamber to set the manner of debate for a related bill. It must be agreed to in the chamber in which it was introduced. It is not voted on in the other chamber and does not have the force of law.
The resolution’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a resolution will move past the committee stage.
There have been no votes related to this resolution.
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.Res. 279 — 112th Congress: Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.. Retrieved from https://www.govtrack.us/congress/bills/112/hres279
“H.Res. 279 — 112th Congress: Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs..” www.GovTrack.us. 2011. March 3, 2015 <https://www.govtrack.us/congress/bills/112/hres279>
|title=H.Res. 279 (112th)
|accessdate=March 3, 2015
|author=112th Congress (2011)
|date=May 25, 2011
|quote=Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.